Drugs / Chinese Herbal Compound Ointment
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02733731 | Feb → May 2016 | postmenopausal atrophic vaginitis | First Affiliated Hospital, Sun Yat-Sen University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chinese Herbal Compound Ointment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02733731 ↗ |
| Known as | CHCO | “Subjects received CHCO (Chinese Herbal Compound Ointment) topical vaginal application in experimental group, while estriol in control group.” NCT02733731 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “This kind of CHCO composed of several chinese herbs,dong quai,angelica,resina draconis and lithospermum.” NCT02733731 ↗ |
| Route | Other | “The traditional chinese medicine oil and estriol cream were separately intravaginal administrated in treatment group and control group for 3 weeks，follow-up 1 month.” NCT02733731 ↗ |